Gilead Sciences (GILD) Announces 2-for-1 Stock Split
Gilead Sciences, Inc. (Nasdaq: GILD) said its Board of Directors has approved a two-for-one stock split of the company's outstanding common stock to be effected through a stock dividend. Stockholders of record as of the close of business on May 24, 2007 will receive a stock dividend of one additional share of common stock for every share of common stock they own.
You May Also Be Interested In
- Gilead Sciences (GILD) Epclusa Approval Secures Near-Term HCV Dominance - BMO Capital
- Aytu BioScience (AYTU) Announces 1-for-12 Reverse Stock Split
- Gilead (GILD) CEO says Epclusa list price will be $74,760 for 12 weeks - Bloomberg
Create E-mail Alert Related CategoriesStock Splits
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!